The Bronte Amalthea Fund is a global long/short fund targeting double digit returns over the long term, managed by a performance orientated firm with a process and portfolio that is genuinely different. Objectives include lowering the risk of permanent loss of capital and providing global diversification without the market/drawdown risks typical of long-only funds. A highly diversified short book substantially reduces risk and enables profits to be made in tough markets. The fund is an alternative to equity investing, and complement to most portfolios, and is typically an excellent diversifier which may lower overall portfolio risk.
Amalthea commenced the new financial year by delivering a net return of 2.5%, handily beating the MSCI ACWI (a broad based global index) when measured in AUD. Markets were up hard with the ACWI lifting by 4.34% in US dollar terms and 2.22% measured in Australian dollars. For a long/short fund keeping up with such increases is unusual and not surprisingly our shorts proved a drag but were more than made up for by significant gains in key longs including Herbalife, Alphabet (nee Google) and Adidas.
The Talas Turkey Value Fund returned 9.5% net for the first quarter on a concentrated portfolio in which 93% of its capital is invested in 14 holdings. The MSCI Turkey Index returned 13.1% for the first quarter, while the MSCI All-Country ex-USA was down 5.4%. Background of the Talas Turkey Value Fund Since its inception Read More
During the month the distribution for the 2016 financial year was also calculated and a 34.35 payment made to unit holders.
See the full PDF below.